Newsroom | 10148 results

BOSTON--(BUSINESS WIRE)--Go dēhp® and dēhp® Theraputic CEO Josette Sullins and Dr. Maria Navarro DBH, LPC, TAD, EMDR-C, Chief Behavioral Health Officer and Clinical Director of Go dēhp® and dēhp® Theraputic, are showcasing their proprietary Dehp® High treatment Friday, May 29, 2026, at the 37th Annual Boston International Trauma Conference. Attendees of the sponsored dēhp Therapeutic Lunch and Learn during the conference will receive an introductory overview of the dIT and explore the stages of...

PARIS & NEW HAVEN, Conn.--(BUSINESS WIRE)--ReST Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapeutics for stress and trauma-related disorders through precision neuropsychiatry, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for RST-101, its lead investigational therapeutic candidate for the early treatment of post-traumatic stress disorder (PTSD). The IND acceptanc...

NEWTON, Mass.--(BUSINESS WIRE)--Draig Therapeutics, a clinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies, presented today an oral presentation and two posters at the American Society for Clinical Psychopharmacology (ASCP) Annual Meeting. Draig’s pipeline of highly specific AMPA and GABAA receptor modulators are designed to enable safe, precise modulation of the major neurocircuits underlying neuropsychiatric disorders. The Company’s lead...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Evecxia Therapeutics, Inc.—a clinical-stage neuroscience company developing a novel class of Serotonin Synthesis Amplification therapies—today announced the publication of the peer-reviewed article titled “Serotonin Synthesis Amplification to Augment the Therapeutic Efficacy of Serotonin Reuptake Inhibitor Antidepressants - Five Decades of Clinical Evidence” in the Journal of Clinical Psychopharmacology. The review article was co-authored with Dr....

WASHINGTON--(BUSINESS WIRE)--Soon, schools across the country let out for summer. For tens of millions of kids, that means significantly more time on phones, tablets, gaming consoles, and apps their parents may never have heard of. For most families, it also means heading into the season underprepared for what their kids are actually encountering online. Today, Stanford Social Media Lab, in collaboration with the Family Online Safety Institute (FOSI) and California Partners Project, released A...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced the appointment of Andrew Miller, Ph.D. to its Board of Directors, effective May 27, 2026. “We are thrilled to welcome Andrew to Alto’s Board at a transformative time for the Company,” said Amit Etkin, M.D., Ph.D., Founder and Chief Executive Officer of Alto Neuros...

SEATTLE--(BUSINESS WIRE)--Frazier Healthcare Partners ("Frazier"), a private equity firm focused exclusively on the healthcare industry, today announced the closing of its acquisition of Altruix (the “Company”). Altruix, headquartered in Hunt Valley, MD, is a leading behavioral health-focused pharmacy serving patients with severe mental illness (SMI), substance use disorders (SUD), and intellectual and developmental disabilities (IDD). The Company’s differentiated care model combines high-touch...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the election of Kathleen Tregoning to its Board of Directors at the annual general meeting of shareholders. Ms. Tregoning is expected to serve on the Compensation and Leadership Development Committee and the Nominating and Corporate Governance Committee. She brings extensive experience guiding bio...

CHEVY CHASE, Md.--(BUSINESS WIRE)--Caring Men Global, a nonprofit dedicated to supporting male caregivers facing a loved one’s cancer, has received a grant from Exelixis to launch “Strong Caregivers, Stronger Survivors,” a caregiver-centered cancer recurrence prevention program designed to prepare men to effectively support cancer survivors following treatment. Survivors are often most vulnerable after active treatment ends, when medical oversight decreases and responsibility for prevention, mo...

NEW YORK--(BUSINESS WIRE)--The Youth Mental Health Corps, a groundbreaking national service initiative founded by the Schultz Family Foundation and Pinterest to address the escalating youth mental health epidemic while helping build the next generation of behavioral health professionals, has announced its expansion into 16 states for the 2026–2027 school year. Fueled by growing national and local support, including new investment from Ballmer Group, YMHC is scaling its innovative near-peer mode...